ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Portage Biotech Inc

Portage Biotech Inc (PRTG)

0.5633
0.0233
(4.31%)
Closed March 29 04:00PM
0.55
-0.0133
(-2.36%)
After Hours: 07:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.5633
Bid
0.51
Ask
0.64
Volume
17,067
0.55 Day's Range 0.64
0.34 52 Week Range 4.40
Previous Close
0.54
Open
0.571
Last Trade Time
Average Volume (3m)
65,774
Financial Volume
$ 9,726
VWAP
0.569852

PRTG Latest News

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Filed Pursuant to Rule 424(b)(3) Registration No. 333-275229 PROSPECTUS SUPPLEMENT (to Prospectus dated November 7, 2023)     Portage Biotech Inc.   9,631,580 Ordinary Shares...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Filed Pursuant to Rule 424(b)(3) Registration No. 333-275229   PROSPECTUS SUPPLEMENT (to Prospectus dated November 7, 2023) Portage Biotech Inc.   9,631,580 Ordinary Shares...

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company advancing novel multi-targeted...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 6-KREPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934For...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.113225.14996667410.45010.80.451384130.55413935CS
4-0.1489-20.90704858190.71220.80.45601500.55898667CS
12-0.9267-62.19463087251.491.740.34657740.66594496CS
26-1.7267-75.40174672492.292.930.34485061.0270335CS
52-2.0867-78.74339622642.654.40.34324551.54326525CS
156-30.4467-98.18348919731.0144.97630.34326769.68043952CS
260-36.9367-98.497866666737.544.97630.34321559.96087937CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

PRTG Discussion

View Posts
glenn1919 glenn1919 1 month ago
PRTG.........................................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 month ago
Ugliness and failure
👍️0
mauiguy2 mauiguy2 1 month ago
Monk, if you're going to take the time to post on this board, at least post the chart of the right company. You posted the chart of CLH, not PRTG.

I owned PRTG a long time ago, but still follow its progress. Lack of progress is a better word!!
👍️0
Monksdream Monksdream 1 month ago
PRTG new 52 week low
👍️0
Monksdream Monksdream 2 months ago
PRTG new 52 week low
👍️0
shmully shmully 9 months ago
Can you tell me if longtime shareholders of PRTG will be getting shares of the spinoff INTS? Thank you.
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
PRTG ready for 4.72
👍️0
Triple nickle Triple nickle 10 months ago
Slow and steady
👍️0
Virginia Prospector Virginia Prospector 3 years ago
Yes, it has been rough. IMO low volume and anticipated progress setback due to covid delays caused share price to rise too fast. Then a big holder sold half their stake at $40+. Going forward I expect a slower, sustained rise driven by positive news. I did sell some on the way down but now beginning to add. The future looks bright.
👍️0
mauiguy2 mauiguy2 3 years ago
Actually, it's a good letter. It's been a rough last couple of months, hasn't it, VP?
👍️0
Virginia Prospector Virginia Prospector 3 years ago
Shareholder letter gives update and roadmap for the future:
https://www.portagebiotech.com/wp-content/uploads/2021/08/Portage-PR-Shareholder-Letter-8.12.2021-FINAL.pdf
👍️0
conix conix 3 years ago
PRTG Chart

👍️0
Nightroads Nightroads 3 years ago
PRTG owns approximately 10%. Intensity Therapeutics is involved in two studies now. Phase 2 with Merck and Bristol Meyers. Phase 2 in Canada at the Ottawa Hospital. Here is the clinical study page for Intensity.

https://intensitytherapeutics.com/clinical-research/

I've been in this for quite awhile. Looks exciting over the next 30-90 days. Portage Biotech has a tremendous pipeline of drugs and the CEO and Management Team are mostly all ex-big pharma specialists. Ian Walters, the CEO is particularly worth doing some DD on.
👍️0
bbhuey bbhuey 3 years ago
I was on the stockists board and saw the info on Intensity and tumor killing properties that Portage has invested in.
Does anyone know the current size of their investment and have any further info on Intensity progress?
👍️0
Virginia Prospector Virginia Prospector 3 years ago
Portage making the right moves to advance portfolio. Watch for much progress this year.

https://longevity.technology/juvenescence-scoops-up-new-longevity-ip/
👍️0
Renee Renee 3 years ago
PTGED changed to PRTG. Moved to the Nasdaq from the OTC:

https://www.sec.gov/Archives/edgar/data/1095435/000106299321001977/exhibit99-1.htm

https://otce.finra.org/otce/dailyList?viewType=Deletions
👍️0
mauiguy2 mauiguy2 3 years ago
Finally....a good update from the CEO. Nice to see. Definitely worth a read.

https://finance.yahoo.com/news/ceo-spotlight-portage-biotech-ceo-131700124.html
👍️0
bbhuey bbhuey 4 years ago
Does anyone know what catalysts are coming .

It seems that lik.this stock is taking a nap.
👍️0
pmunch pmunch 4 years ago
News : Private Placement PTGED
https://www.otcmarkets.com/stock/PTGED/news/story?e&id=1625752
👍️0
Renee Renee 4 years ago
PTGEF one for 100 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
Virginia Prospector Virginia Prospector 4 years ago
New CFO recently announced and now preparing for uplist.

https://finance.yahoo.com/news/portage-announces-non-brokered-private-120000259.html
👍️0
bbhuey bbhuey 4 years ago
I think they may have shareholder approval .
I think over 50 percent is owned by management
but even after the filings they have not immediately decided to do that yet.
Ithink if they had to traipse capital they would effect the reverse split.
👍️0
Virginia Prospector Virginia Prospector 4 years ago
I saw it an update for shareholder approval, which they did get. I had this pasted to word doc:

“The Company will also be seeking shareholder approval to a consolidation of its common shares up to a ratio of 120:1 with the final exchange ratio and implementation date to be determined at the discretion of the directors of the Company. As required under the CSE rules, a name change will accompany such consolidation if, as and when effected. The Company is seeking approval at this time to allow it flexibility to implement these corporate changes as business circumstances dictate (such as a financing or senior exchange listing).”
👍️0
bbhuey bbhuey 4 years ago
Where did they reference that ?

Do you know what the current issued and outstanding on prgef?
👍️0
Virginia Prospector Virginia Prospector 4 years ago
up to 120:1
👍️0
bbhuey bbhuey 4 years ago
Does anyone remember what the reverse split ratio will be?
👍️0
bbhuey bbhuey 4 years ago
I think if you download the seeking alpha app on your phone you may not have to be a Pro member
👍️0
Virginia Prospector Virginia Prospector 4 years ago
I believe you need to subscribe to read older articles. This one I follow is several years old.

https://seekingalpha.com/article/4004355-portage-biotech-management-provides-key-insight-strategic-vision-stock-remains-extremely

Uplist to Nasdaq expected in near future. Stock is considerably undervalued and many will be buying before uplisting.
👍️0
mauiguy2 mauiguy2 4 years ago
Yes, I found the website easily. However, I didn't see a message board section. Didn't look very long, though. Do you need to be a member to access the message board?
👍️0
bbhuey bbhuey 4 years ago
It is called SeekingAlpha.com
👍️0
mauiguy2 mauiguy2 4 years ago
I tried to find the message board there, but couldn't find it. Is it a paid site?
👍️0
bbhuey bbhuey 4 years ago
Hi. I had some of those original shares and got the stock dividend of bhvn and sold them when they were in the 30s.
A better site for comments on ptgef is the Seeking Alpha site
👍️0
mauiguy2 mauiguy2 4 years ago
I totally totally understand everything you've written.

The reason I asked those questions is because I had always wondered what happened to those PTGEF investors, like yourself, who decided to sell all their shares after the dividend was announced, but before the distribution date. I was wondering if an investor could have sold at the higher price just before the distribution date and still qualify for the dividend. But, in your case, you didn't qualify for the dividend.

Anyway, getting back to our earlier discussion.... if there's going to be an RS, I hope it will be minimal and it will still give PTGEF the ability to grow exponentially with its share price as it did last time.

I think the prospects now look good. Unfortunately, all those accounting issues were a fiasco and it hurt the investors for over a year. I hope management has learned from its mistakes and delays. It's now time to move forward.
👍️0
ronpopeil ronpopeil 4 years ago
Correct. I had owned ptgef for a while. Loved the potential based on their positions but of course bhvn which was set to ipo. Many didn’t realize how much of bhvn ptgef owned. When the stock went to the $.60s I sold as I had made a good profit and didn’t want to be too greedy. I guess if I held, took the dividend and then sold bhvn at the highs I would’ve done better but it’s just, I still follow ptgef but don’t win any now. I still worry about the reverse split because I thought I remember reading about a large reverse split which would pit the stock price in double digits
👍️0
mauiguy2 mauiguy2 4 years ago
So, you didn't receive any BHVN shares, correct?
👍️0
ronpopeil ronpopeil 4 years ago
I sold before the bhvn dividend.
👍️0
mauiguy2 mauiguy2 4 years ago
I'm a little unclear by your answer. Did you actually sell PTGEF in the .60's? Or, did you hold on until the BHVN dividend and then sell PTGEF at the much lower post dividend price?
👍️0
ronpopeil ronpopeil 4 years ago
I agree. I owned ptgef when it was like .10 and rode it to over .60 before selling and taking the bhvn shares. I’d buy in here but worried about the size of the reverse split.
👍️0
mauiguy2 mauiguy2 4 years ago
I certainly hope it's not as big of an RS as you mentioned. A 250 RS is really big. And, I'll tell you why I don't like the idea.

I was a PTGEF shareholder before the BHVN dividend. Without checking the actual numbers, I remember the situation as being something like this:

During that final year, PTGEF moved basically from where were are now up to the .60's before it retreated a bit before the actual dividend. There was something like a 6x gain during that period. If there's a 250 RS, let's say we wind up at 25. Moving up 6x to 150 in a very short period of time is very unlikely.

Better yet, let me use yesterday's example. At one point in the day, we were up nearly 50%. It's very rare that a $25 stock moves up 50% in a day without exceptionally good news. Sure, there are some examples, but it doesn't happen often.

If an RS actually does take place, I'd like to see the new price be in single digits.

Anyway, these are just my thoughts. Actually, I don't like RS's at all. The majority of them end up as disasters. But, yes, occasionally they can be effective if done by a good company.
👍️0
ronpopeil ronpopeil 4 years ago
Yeah I heard it could be pretty large like 1 for 250
👍️0
mauiguy2 mauiguy2 4 years ago
We don't know yet. It hasn't been announced.
👍️0
ronpopeil ronpopeil 4 years ago
What is the ratio for the reverse split going to be?
👍️0
mauiguy2 mauiguy2 4 years ago
This is the first post on this board in over 3 months. Probably most of you who are reading this post are aware there's been some good company news recently. Trade volume today was 3/4's of a million shares. I can't remember the last time we came anywhere close to that trade volume. Hopefully, we're now getting out of the woods with all our accounting issues. May the path be clear and bright as we look towards the future with PTGEF!
👍️0
Virginia Prospector Virginia Prospector 4 years ago
Material status change filed today with CSE. Expect reinstatement soon.

https://webfiles.thecse.com/sedar_filings/00008656/2001091113074528.pdf

"The material change is reflected in the March 31, 2019 annual financial statements which
disclose a substantial increase in the value of the assets of the Company from approximately
US$10,000,000 as at March 31, 2018 to US$173,000,000 as at March 31, 2019; a change of
1700%."
👍️0
Golden Cross Golden Cross 4 years ago
Here you go BullsMD...GL $PTGEF

https://www.otcmarkets.com/stock/PTGEF/disclosure



👍️0
BullsMD BullsMD 4 years ago
Link?
👍️0
Golden Cross Golden Cross 4 years ago
Tier_Change= Grey Market to Pink No Information $PTGEF
👍️0
Golden Cross Golden Cross 4 years ago
Get your tickets here Back on Pink Sheets
👍️0
Nightroads Nightroads 4 years ago
It appears that Ian has purchased in excess of a million+ shares in a private transaction.
👍️0
TP-Money TP-Money 4 years ago
I have it in for an extended time frame. Lets see what happens.
👍️0

Your Recent History

Delayed Upgrade Clock